Efficient drug delivery at vaginal cavity is often a challenge owing to its peculiar physiological variations including vast differences in pH. Keeping in view this attribute of the target site, the c
Efficient drug delivery at vaginal cavity is often a challenge owing to its peculiar physiological variations including vast differences in pH. Keeping in view this attribute of the target site, the c
A relationship between the vaginal microbiota and tenofovir (TFV) concentrations and activity after topical administration has been previously reported. CONRAD A15-138 was a randomized, placebo-contro
The data is from a human study where six HSV-positive women wore intravaginal rings delivering the antiviral agent acyclovir. The intravaginal rings were developed by our group. Three women wore them
The data is from a human study where six HSV-positive women wore intravaginal rings delivering the antiviral agent acyclovir. The intravaginal rings were developed by our group. Three women wore them